Serum Institute of INdia
SII to restart COVID vaccine trials as India tally breaches 50L mark
The trials of the Oxford COVID-19 vaccine candidate were halted world over after one volunteer developed 'unexplained illness'
Trials will have ups and downs, say scientists
Adverse effects were noted on two human subjects who volunteered for the phase 3 trials of AstraZeneca COVID-19 vaccine
COVID-19 in India: Serum Institute halts trials of AstraZeneca's vaccine
The move came a day after the company stated that it would push ahead with the trials in India
Serum Institute of India: India will go ahead with Oxford COVID vaccine trials
The SII has been issued a show cause notice by Indian drug controller DCGI after one volunteer reported unwell in UK
AstraZeneca's COVID-19 vaccine trials continue in India: Serum Institute
AstraZeneca said it has paused global trials, including large late-stage trials, due to an unexplained illness in a study participant
Two volunteers who were given Oxford vaccine are fine
The vaccine trials are being conducted by the Serum Institute of India in Pune
Phase-2 human trial of the Oxford COVID-19 vaccine candidate begins in India
The phase-2 trial will be conducted on 100 volunteers at some sites across the country.
Serum Institute begins phase 2 clinical trial of Oxford COVID vaccine
In all 25 candidates will given the vaccine in the next seven days, according to Dr Lalwani
Serum-Oxford COVID-19 vaccine gets DCGI grant for human trials in India
The panel had also recommended that the clinical trial sites which have been proposed for the study be distributed across India
Indian firm to test Covid vaccine in 3 weeks; if successful, drug won't be patented
If human clinical trials are successful, product will be out in the market by October